EUVIMEDOpdag EUVIMED
Crossref

Conversión de la prueba de tuberculina en un programa de residencia en pediatría en México: estudio prospectivo de cinco años

José Iván Castillo Bejarano, Manuel de la O-Cavazos, Fernando García Rodríguez, Carlos Alberto Hernández Salas, Juan Carlos Luévanos Gurrola, Denisse Vaquera Aparicio, Abiel Mascareñas de los Santos

Revista Latinoamericana de Infectología Pediátrica · 2021

DOI: 10.35366/102967 ↗

At a glance

Journal article in Revista Latinoamericana de Infectología Pediátrica, 2021. Written by José Iván Castillo Bejarano and 6 co-authors. 10 references.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

In Mexico, screening for latent tuberculosis is not a systematized program.The objective was to evaluate the prevalence, incidence rate and risk factors for purified peptide derivative (PPD) conversion in a pediatric residency program in Nuevo Leon, Mexico.The objective was to evaluate the prevalence, incidence rate and risk factors for purified peptide derivative (PPD) conversion in a pediatric residency program in Nuevo Leon, Mexico.Material and methods: Cohort study, involving residents of a public hospital in Mexico, demographic and clinical data were collected.A PPD induration ≥ 10 mm was considered positive.PPD conversion was defined as a result ≥ 10 mm in students with a previous negative result.The Wilcoxon rank test was used and a logistic regression analysis was performed to measure the association of possible factors for PPD reactivity.The conversion rate was subjected to McNemar's test.

Results

99 students were followed up, 54% were female.The baseline prevalence of positive PPD was 21%.The prevalence of conversion was 25%.Conversion was higher (20.4%) in first-year residents.The conversion rate was 10.5/1,000 person-months, with a higher prevalence in first-year residents (13.6/1,000 person-months).The probability of presenting a baseline positive result was higher in students with previous exposure to a case of tuberculosis (OR; 3.36 [95% CI 1.3-8.2]).

Conclusions

Our study identifies a high prevalence and incidence of PPD conversion in pediatric residents in Mexico.The design of more stringent preventive strategies is necessary to prevent tuberculosis infection in our population.

Cite

APA

Bejarano, J. I. C., O-Cavazos, M. D. L., Rodríguez, F. G., Salas, C. A. H., Gurrola, J. C. L., Aparicio, D. V., & Santos, A. M. D. L. (2021). Conversión de la prueba de tuberculina en un programa de residencia en pediatría en México: estudio prospectivo de cinco años. Revista Latinoamericana de Infectología Pediátrica. https://doi.org/10.35366/102967

Vancouver

Bejarano JIC, O-Cavazos MDL, Rodríguez FG, Salas CAH, Gurrola JCL, Aparicio DV, et al. Conversión de la prueba de tuberculina en un programa de residencia en pediatría en México: estudio prospectivo de cinco años. Revista Latinoamericana de Infectología Pediátrica. 2021. doi:10.35366/102967

BibTeX
@article{Bejarano2021,
  author = {Bejarano, José Iván Castillo and O-Cavazos, Manuel de la and Rodríguez, Fernando García and Salas, Carlos Alberto Hernández and Gurrola, Juan Carlos Luévanos and Aparicio, Denisse Vaquera and Santos, Abiel Mascareñas de los},
  title = {Conversión de la prueba de tuberculina en un programa de residencia en pediatría en México: estudio prospectivo de cinco años},
  journal = {Revista Latinoamericana de Infectología Pediátrica},
  year = {2021},
  doi = {10.35366/102967}
}
Start for free →